Advances in targeted alpha therapy for prostate cancer. [electronic resource]
- Annals of oncology : official journal of the European Society for Medical Oncology 11 2019
- 1728-1739 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1569-8041
10.1093/annonc/mdz270 doi
Actinium Alpha Particles--therapeutic use Clinical Trials, Phase III as Topic Dipeptides--pharmacology Heterocyclic Compounds, 1-Ring--pharmacology Humans Male Precision Medicine--methods Progression-Free Survival Prostate-Specific Antigen--antagonists & inhibitors Prostatic Neoplasms--genetics Radioimmunotherapy--adverse effects Radiopharmaceuticals--pharmacology Radiotherapy Planning, Computer-Assisted Tumor Microenvironment--drug effects